Ocular Therapeutix Inc
NASDAQ:OCUL
Ocular Therapeutix Inc
NASDAQ:OCUL
Price:
6.24 USD
-0.79%
Updated:
May 21, 2024
Ocular Therapeutix Inc
Cash from Investing Activities
|
Ocular Therapeutix Inc
Cash from Investing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
Cash from Investing Activities
-$3m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-16%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
-$2.9B
|
CAGR 3-Years
48%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$33.9B
|
CAGR 3-Years
-79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$13.1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.6B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
See Also
What is Ocular Therapeutix Inc's Cash from Investing Activities?
Cash from Investing Activities
-3m
USD
-3m
USD
Based on the financial report for Mar 31, 2024, Ocular Therapeutix Inc's Cash from Investing Activities amounts to -3m USD.
What is Ocular Therapeutix Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-16%
-16%
Over the last year, the Cash from Investing Activities growth was 57%. The average annual Cash from Investing Activities growth rates for Ocular Therapeutix Inc have been -58% over the past three years , -6% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
